A STUDY ON THE ASSOCIATION OF IL‑1RAVNTR AND IL‑1α (С+889T) GENE POLYMORPHISMS WITH FEATURES OF ESSENTIAL HYPERTENSION
- Authors: Radaeva O.A.1, Simbirtsev A.S.2
-
Affiliations:
- Mordovian State N. P. Ogariov University
- State Research Institute of Highly Pure Biopreparations
- Issue: Vol 21, No 2 (2018)
- Pages: 118-127
- Section: ORIGINAL ARTICLES
- Submitted: 15.04.2020
- Accepted: 15.04.2020
- Published: 15.04.2018
- URL: https://rusimmun.ru/jour/article/view/65
- ID: 65
Cite item
Full Text
Abstract
Objective: the analysis of the relationship between polymorphisms IL1-raVNTR, С+889T gene IL-1α and features of essential hypertension (the risk myocardial infarction and stroke among men and women).
Methods: The 300 patients with II stage essential hypertension were followed for 8 years. Polymorphism of cytokine genes (IL-1ra (86 bp VNTR),–889C/T IL-1α) were examined by the method restrictor analysis of amplification products specific regions of the genome. Concentrations of IL-1ra, IL-1α in serum were measured by ELISA (test systems eBioscience (Bender MedSystems)).
Results: Genotyping of interleukin 1 receptor antagonist genes (IL-1ra86bp VNTR) has shown positive associations between the intron 2 IL-1ra – 4R/4R, 5R/5R microsatellite polymorphism and the risk of arterial hypertension development. The 5R/5R, 2R/2R were associated significantly with risk of stroke and myocardial infarction in patients with essential hypertension. Patients with polymorphisms of IL-1ra 4R/4R and 5R/5R have a lower concentration of IL-1Pa and higher levels of IL-1α in serum than otherpatients. Variant TT polymorphism –889C/T IL-1α is correlated with an increase in the concentration of IL-1α in the serum, without changing the frequency of hypertension, but increases the risk of myocardial infarction and stroke in patients with hypertension (mostly women). Allele 4R/4R (IL1-raVNTR) is associated with hypertension and its combination with – TT variant with IL-1alpha (C + 889T) polymorphisms contribute to the development of myocardial infarction and stroke in women.
Keywords
About the authors
O. A. Radaeva
Mordovian State N. P. Ogariov University
Author for correspondence.
Email: vtlbwbyf_79@mail.ru
PhD (Medicine), docent of chair of Immunology, Microbiology, Virology
26a, St. Ulyanova, Saransk
Russian FederationA. S. Simbirtsev
State Research Institute of Highly Pure Biopreparations
Email: fake@neicon.ru
PhD, MD (Medicine), Professor, Corresponding member of the Russian Academy of Sciences, deputy director of Institute of Highly Pure Biopreparations
7, St. Pudozhsky, St. Petersburg
Russian FederationReferences
- Rodriguez-Iturbe B., Pons H., Quiroz Y. The Immunological Basis of Hypertension. American Journal of Hypertension 2014, 27(11), 1327–1337.
- Vanhala M., Kautiainen H., Kumpusalo E. Proinflammation and hypertension: a population-based study. Mediators of Inflammation, vol. 2008, Article ID619704, 7 pages. doi: 10.1155/2008/619704
- Peddareddygari L.R., Sen S., PahwaA., Levenstien M.A., Grewal R.P. Analysis of the interleukin-1 receptor antagonist gene variable number tandem repeats in ischemic stroke. J. Stroke Cerebrovasc. Dis. 2014, 23(6), 1599–1603.
- Gromadzka G., Sarzynska-Dlugosz I., Czlonkowska A. IL1R Nintron 2 polymorphism caused by variable number tandem repeats is associated with 1-year outcome in patients with ischaemic stroke. J. Neurol. Neurosurg. Psychiatry. 2007, 78(2), 183–186.
- Симбирцев А.С. Интерлейкин-1. Физиология. Патология. Клиника. Спб.: Фолиант, 2011, 480. [Simbirtsev A.S. Interleukin-1. Physiology. Pathology. Clinic. “Izdatel’stvoFoliant”, St. Petersburg, 2011, 480].
- Goto H., Ishihara Y., Kikuchi T., Izawa A., Ozeki N. Interleukin-1 Receptor Antagonist Has a Novel Function in the Regulation of Matrix Metalloproteinase-13 Expression. PLoS ONE2010, 10(10), e0140942. http://doi.org/10.1371/
- Радаева О.А., Симбирцев А.С. Гендерные особенности системы интерлейкина-1 у женщин с эссенциальной артериальной гипертензией. Цитокины и воспаление 2014, Т. 13, № 3, 31–37. [Radaeva O.A., Simbirsev A.S. Gender-dependent changes in interleukin 1 system in women with essential arterial hypertension. Cytokines and Inflammation 2014, T. 13, № 3, 31–37].
- Boodram Laura-Lee. Extraction of genomic DNA from whole blood / Protocol Online – Your Lab's Reference Book – online database of research protocols in a variety of life science fields. 1999–2006. http://www.proto-colorg/prot/Protocols/Extraction-of-genomic-DNA-from-whole-blood-3171.html.
- Goracy J., Goracy I., Safranow K., Taryma O. Lack of association of interleukin-1 gene cluster polymorphisms with angiographically documented coronary artery disease: demonstration of association with hypertension in the Polish population. Arch. Med. Res. 2011, 42(5), 426–432.
- Aren W.P., Malyak M., Guthridge C.J. Interleukin-1 receptor antagonist: Role in Biology. Annu. Rev. Immunol. 1998, 16, 2–55.
- Nicklin M.J., Hughes D.E., Barton J.L., Ure J.M., Duff G.W. Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J. Exp. Med. 2000, 191(2), 303–312.
- Witkin S.S., Gerber S., William J. Ledger Influence of Interleukin-1 Receptor Antagonist Gene Polymorphism on Disease. Clin. Infect. Dis. 2002, 34 (2), 204–209
- Herbert A., Cruickshank J.K., Laurent S., Boutouyrie P. Establishing reference values for central blood pressure and its amplification in a general healthy population and according to cardiovascular risk factors. Eur. HeartJ. 2014, 35(44), 3122–3133.
- Xu S., Zhi H., Hou X., Cohen R.A., Jiang B. IκBβ attenuates angiotensin II–induced cardiovascular inflammation and fibrosis in mice. Hypertension 2011, 58, 310–316.